Aug 06, 2020

Report: Biopharma CEOs score 'supersalaries' even as sales decline | FiercePharma

Eli Lilly's John Lechleiter was one of six pharma CEOs to make the New York Times2013 executive-pay ranking, but he wasn't at the top of the list of highly paid drug industry execs. That position went to Abbott's Miles White, who saw his pay rise 8% to $20.5 million, placing him in the 13th spot overall on the NYTlist.

Proceed to the page: http://linkis.com/QLQam

Similar Articles Added Earlier

Similar Articles Added Today

  • 167185.pdf | DocDroid

    When pondering real estate, the very first thing that typically relates to thoughts is your own home. Having said that, Actual physical Qualities could also Perform a large element in the portfolio, Specially for a border towards the inventory industry. Although house investment in Dubai happens to...

  • Allie ’s Presentations on authorSTREAM

    When you or another person you like has started to encounter Listening to decline, than you recognize firsthand what a great loss hearing reduction really is.

  • VALORANT PC Game Highly Compressed Free Download

    Valorant is a tactical first-person shooter game. Riot Games developed and published the game for Microsoft Windows. Valorant PC is an earlie

Most Recent fiercepharma.com Articles

Latest Links Processed

0/120